HUYABIO International
Farbod Shojaei has held key positions in various pharmaceutical companies, driving drug discovery and development in the field of oncology. With extensive experience in translational medicine and cancer biology, Farbod has managed drug discovery programs, investigated biomarkers of response to anti-cancer compounds, and led combination strategies for overcoming drug resistance. Farbod's research has contributed to understanding mechanisms of action in oncology, showcasing a strong background in immunology.
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.